Cargando…

Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455

Ionizing radiation activates cytoprotective pathways in cancer cells. Fibroblast growth factor receptor (FGFR) is a key player in these pathways. Thus, FGFR signaling is a potential target to induce radiosensitization. LY2874455 is an orally administrable selective pan-FGFR inhibitor. However, the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darwis, Narisa Dewi Maulany, Horigome, Eisuke, Li, Shan, Adachi, Akiko, Oike, Takahiro, Shibata, Atsushi, Hirota, Yuka, Ohno, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179643/ https://www.ncbi.nlm.nih.gov/pubmed/35681425 http://dx.doi.org/10.3390/cells11111727

Ejemplares similares

Crystal Structure of the FGFR4/LY2874455 Complex Reveals Insights into the Pan-FGFR Selectivity of LY2874455
por: Wu, Daichao, et al.
Publicado: (2016)

Reporting of methodologies used for clonogenic assays to determine radiosensitivity
por: Oike, Takahiro, et al.
Publicado: (2020)

Comparison of Clonogenic Survival Data Obtained by Pre- and Post-Irradiation Methods
por: Oike, Takahiro, et al.
Publicado: (2020)

Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma
por: Hanes, Robert, et al.
Publicado: (2019)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

High tumor mutational burden predicts worse prognosis for cervical cancer treated with radiotherapy
por: Ota, Norichika, et al.
Publicado: (2021)

Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance
por: Dehghanian, Fariba, et al.
Publicado: (2021)

Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion
por: Kim, Sun Young, et al.
Publicado: (2017)

FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2019)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC
por: Liu, Dongcheng, et al.
Publicado: (2022)

Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity
por: Matsui, Toshiaki, et al.
Publicado: (2019)

Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses
por: Anakura, Mai, et al.
Publicado: (2019)

Unresectable cutaneous metastatic tumor in the arm that underwent complete remission after radiotherapy
por: Oike, Takahiro, et al.
Publicado: (2020)

Induction of Micronuclei in Cervical Cancer Treated with Radiotherapy
por: Kobayashi, Daijiro, et al.
Publicado: (2020)

Radiotherapy With Hydrogen Peroxide-Soaked Gauze for Unresectable Breast Cancer
por: Oike, Takahiro, et al.
Publicado: (2021)

Radiotherapy With Hydrogen Peroxide-Soaked Gauze for Preauricular Sebaceous Carcinoma
por: Adachi, Akiko, et al.
Publicado: (2022)

Relative Biological Effectiveness of Carbon Ions for Head-and-Neck Squamous Cell Carcinomas According to Human Papillomavirus Status
por: Osu, Naoto, et al.
Publicado: (2020)

The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells
por: Amornwichet, Napapat, et al.
Publicado: (2015)

Palliative radiation therapy for bleeding from gastric cancer: A case series of seven patients
por: Ota, Norichika, et al.
Publicado: (2023)

Molecular mechanisms underlying radioresistance: data compiled from isogenic cell experiments
por: Oike, Takahiro, et al.
Publicado: (2020)

(64)Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity
por: Nachankar, Ankita, et al.
Publicado: (2021)

Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460
por: Kubo, Nobuteru, et al.
Publicado: (2015)

Analysis of the relationship between LET, γH2AX foci volume and cell killing effect of carbon ions using high-resolution imaging technology
por: Oike, Takahiro, et al.
Publicado: (2023)

Novel heterozygous mutation in the extracellular domain of FGFR1 associated with Hartsfield syndrome
por: Takagi, Masaki, et al.
Publicado: (2016)

Inguinal hernia in a patient with prostate cancer to be treated with photon radiotherapy
por: Oike, Takahiro, et al.
Publicado: (2020)

The Non-Cancer Specific Elevation of the Serum Squamous Cell Carcinoma Antigen during the Post-Radiotherapy Follow-Up of Cervical Cancer Patients
por: Oike, Tae, et al.
Publicado: (2021)

Colorectal Cancer Screening Outcomes of 2412 Prostate Cancer Patients Considered for Carbon Ion Radiotherapy
por: Kobayashi, Nao, et al.
Publicado: (2021)

Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors
por: Qu, Lingzhi, et al.
Publicado: (2022)

BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
por: Kim, Se Hyun, et al.
Publicado: (2018)

Leptomeningeal metastasis of uterine cervical cancer 17 years after primary tumor treatment
por: Oike, Takahiro, et al.
Publicado: (2015)

Solitary cardiac metastasis of uterine cervical cancer with antemortem diagnosis: A case report and literature review
por: TSUCHIDA, KEISUKE, et al.
Publicado: (2016)

Quantitative volumetric analysis of the Golgi apparatus following X-ray irradiation by super-resolution 3D-SIM microscopy
por: Oike, Takahiro, et al.
Publicado: (2021)

Mitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin
por: Kobayashi, Daijiro, et al.
Publicado: (2017)

Inter-assay precision of clonogenic assays for radiosensitivity in cancer cell line A549
por: Nuryadi, Endang, et al.
Publicado: (2018)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models
por: Grünewald, Sylvia, et al.
Publicado: (2019)

Definitive Radiation Therapy for Merkel Cell Carcinoma Misdiagnosed as a Metastatic Tumor: A Case Report
por: Matsui, Toshiaki, et al.
Publicado: (2019)

Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy
por: Nuryadi, Endang, et al.
Publicado: (2018)

Semi-Automated Cell Panning for Efficient Isolation of FGFR3-Targeting Antibody
por: Min, Byeongkwi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j0tibf8ialj0u46mmrltdjti85